Forsta Ap Fonden Merck & Co., Inc. Transaction History

Forsta Ap Fonden

$12.8 Billion
Q3 2024

A detailed history of Forsta Ap Fonden transactions in Merck & Co., Inc. stock. As of the latest transaction made, Forsta Ap Fonden holds 668,000 shares of MRK stock, worth $65.7 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

668,000

Previous 607,200 10.01%

Holding current value

$65.7 Million

Previous $75.2 Million 0.91%

% of portfolio

0.59%

Previous 0.67%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$111.15 - $128.97 $6.76 Million - $7.84 Million	60,800 Added 10.01%	668,000 $75.9 Million
Q2 2024 Aug 08, 2024	SELL	$123.8 - $132.96 $7.76 Million - $8.34 Million	-62,700 Reduced 9.36%	607,200 $75.2 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $45,296 - $52,779	400 Added 0.06%	669,900 $88.4 Million
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $1.1 Million - $1.2 Million	11,000 Added 1.67%	669,500 $73 Million
Q3 2023 Oct 25, 2023	BUY	$102.95 - $114.33 $576,520 - $640,248	5,600 Added 0.86%	658,500 $67.8 Million
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $3.08 Million - $3.36 Million	-28,400 Reduced 4.17%	652,900 $75.3 Million
Q1 2023 Apr 21, 2023	SELL	$102.94 - $114.86 $6.53 Million - $7.28 Million	-63,400 Reduced 8.51%	681,300 $72.5 Million
Q4 2022 Feb 02, 2023	BUY	$87.44 - $112.11 $13.1 Million - $16.8 Million	149,600 Added 25.14%	744,700 $82.6 Million
Q3 2022 Oct 17, 2022	SELL	$84.53 - $94.96 $3.41 Million - $3.83 Million	-40,300 Reduced 6.34%	595,100 $51.3 Million
Q2 2022 Aug 11, 2022	SELL	$83.49 - $94.64 $150,282 - $170,352	-1,800 Reduced 0.28%	635,400 $57.9 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $3.87 Million - $4.34 Million	52,700 Added 9.02%	637,200 $52.3 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $1.25 Million - $1.57 Million	17,300 Added 3.05%	584,500 $44.8 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $551,936 - $606,991	7,700 Added 1.38%	567,200 $42.6 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $4.3 Million - $4.76 Million	61,200 Added 12.28%	559,500 $43.5 Million
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $2.67 Million - $3.15 Million	-38,800 Reduced 7.22%	498,300 $38.4 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $8.79 Million - $9.76 Million	122,500 Added 29.55%	537,100 $43.9 Million
Q3 2020 Feb 19, 2021	BUY	$73.18 - $82.95 $30.3 Million - $34.4 Million	414,600 New	414,600 $34.4 Million
Q3 2020 Oct 22, 2020	SELL	$73.18 - $82.95 $28.8 Million - $32.7 Million	-393,700 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $3.8 Million - $4.33 Million	54,000 Added 15.9%	393,700 $30.4 Million
Q1 2020 May 04, 2020	SELL	$63.36 - $87.82 $7.58 Million - $10.5 Million	-119,700 Reduced 26.06%	339,700 $26.1 Million
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $2.89 Million - $3.26 Million	-37,200 Reduced 7.49%	459,400 $41.8 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $3.81 Million - $4.15 Million	50,100 Added 11.22%	496,600 $41.8 Million
Q1 2019 May 08, 2019	BUY	$69.58 - $79.36 $9.6 Million - $11 Million	138,000 Added 44.73%	446,500 $37.1 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $8.86 Million - $10.3 Million	135,800 Added 78.63%	308,500 $23.6 Million
Q3 2018 Nov 07, 2018	BUY	$57.69 - $67.84 $9.96 Million - $11.7 Million	172,700 New	172,700 $12.3 Million
Q1 2018 May 09, 2018	SELL	$50.96 - $59.23 $2.29 Million - $2.67 Million	-45,027 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$51.62 - $61.64 $36,134 - $43,148	-700 Reduced 1.53%	45,027 $2.53 Million
Q3 2017 Oct 31, 2017	BUY	$58.67 - $63.13 $2.68 Million - $2.89 Million	45,727	45,727 $2.93 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account